New drugs need close monitoring
339490
CHICAGO A leading doctor says physicians and patients are obliged to keep a close watch on new prescription drugs for side effects.
270368
Merck &amp; Co.&#39;s recall of the Vioxx painkiller shows why the US Food and Drug Administration needs its safety monitors to be independent of those who approve new medicines, FDA scientist David J. Graham told a Senate hearing.
625730
The first drug to treat female sexual dysfunction isn&#39;t ready for the market yet because of safety concerns, a federal advisory committee cautioned Thursday.
10595
Patients are being put at risk because of the secrecy of drug companies which refuse to publish the results of clinical trials, it was claimed today.
727152
New developments are brewing at the pharmaceutical.
598332
The FDA will review its new cholesterol drug.
368795
The U.S. Food and Drug Administration on Friday asked an outside group to review the way the agency monitors safety risks of medicines after they hit the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
30572
After two highly publicized incidents questioning the safety of some of the biggest selling prescription medicines, the Food and Drug Administration said yesterday it is moving to strengthen its safety monitoring efforts.
512837
Washington --- The Food and Drug Administration, accused in recent weeks of being cozy with the pharmaceutical industry, must open its practices to greater public scrutiny, says a top official of the agency&#39;s besieged Office of New Drugs.
558052
An advisory panel recommends approval of a new HIV drug that blocks one key element.
188339
A little-known Food and Drug program is testing the latest medical technology to determine how safe and useful it can be. One cutting-edge experiment is designed to see if
253901
The public outcry over the withdrawal of the painkiller Vioxx is leading to closer government scrutiny of new drugs to identify and disclose late-developing safety problems.
474870
The U.S. Food and Drug Administration said on Tuesday it was creating a new drug safety board to improve the monitoring of medicines already in the marketplace, a response to charges the agency has failed to protect the public from dangerous side effects.
513761
The U.S. Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
685810
NEW YORK  - Physicians frequently fail to   provide patients with all the information they should have when   they're prescribed new medication, investigators in California   report.
688076
Because of PfizerÂs failed trial, drugs similar to torcetrapib from other companies could face greater scrutiny Â and delays Â in getting to market.
476597
The Food and Drug Administration over the past decade has shifted its budget away from monitoring the safety of drugs on the market, focusing more and more on approving new medicines.